Inhibrx Biosciences (INBX) PT Raised to $300 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: INBX) | Delayed: 81.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.08 | 52 Week High | $ | |||
| Open | $81.08 | 52 Week Low | $ | |||
| Day High | $81.08 | P/E | N/A | |||
| Day Low | $81.08 | EPS | $ | |||
| Volume | 15,313 | |||||
